16.94
Innoviva Inc stock is traded at $16.94, with a volume of 592.66K.
It is down -2.36% in the last 24 hours and down -12.55% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$17.35
Open:
$17.2
24h Volume:
592.66K
Relative Volume:
0.76
Market Cap:
$1.07B
Revenue:
$384.03M
Net Income/Loss:
$38.65M
P/E Ratio:
54.65
EPS:
0.31
Net Cash Flow:
$196.35M
1W Performance:
-2.76%
1M Performance:
-12.55%
6M Performance:
-3.31%
1Y Performance:
-14.44%
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
INVA
Innoviva Inc
|
16.94 | 1.09B | 384.03M | 38.65M | 196.35M | 0.31 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-30-25 | Initiated | Goldman | Sell |
Aug-11-25 | Initiated | Oppenheimer | Outperform |
Jul-14-25 | Initiated | H.C. Wainwright | Buy |
Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
Jul-20-22 | Initiated | Goldman | Neutral |
Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
What Fibonacci levels say about Innoviva Inc. rebound2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
Analyzing recovery setups for Innoviva Inc. investors2025 Risk Factors & Trade Opportunity Analysis Reports - newser.com
What sentiment indicators say about Innoviva Inc. stockJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
How strong is Innoviva Inc. stock revenue growthWeekly Trend Recap & High Conviction Buy Zone Alerts - newser.com
Heatmap analysis for Innoviva Inc. and competitorsEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Innoviva (NASDAQ:INVA) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Technical analysis overview for Innoviva Inc. stockVolume Spike & Comprehensive Market Scan Insights - newser.com
Why Innoviva Inc. (HVE) stock appeals to dividend investors2025 Major Catalysts & Real-Time Price Movement Reports - newser.com
New Strong Buy Stocks for October 10th - sharewise.com
Full technical analysis of Innoviva Inc. stock2025 Short Interest & Accurate Buy Signal Notifications - newser.com
What drives Innoviva Inc stock priceMoving Average Crossovers & Build a Smarter Portfolio Right Now - earlytimes.in
Weiss Ratings Reaffirms "Hold (C)" Rating for Innoviva (NASDAQ:INVA) - MarketBeat
QRG Capital Management Inc. Has $2.26 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critical Care Portfolio at IDWeek 2025 - BioSpace
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critic - PharmiWeb.com
Are Investors Undervaluing Innoviva (INVA) Right Now? - sharewise.com
Using Bollinger Bands to evaluate Innoviva Inc.Market Trend Summary & Daily Technical Forecast Reports - newser.com
Is now a turning point for Innoviva Inc.July 2025 Highlights & Smart Swing Trading Alerts - newser.com
Why Innoviva Inc. stock appeals to dividend seekersJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Applying chart zones and confluence areas to Innoviva Inc.Global Markets & Reliable Intraday Trade Plans - newser.com
How to interpret RSI for Innoviva Inc. stock2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com
Will earnings trigger a reversal in Innoviva Inc.Weekly Risk Summary & Weekly Momentum Picks - newser.com
Is this a good reentry point in Innoviva Inc.Insider Selling & Verified Swing Trading Watchlist - newser.com
Innoviva (NASDAQ:INVA) Stock Rating Lowered by Wall Street Zen - Defense World
Innoviva (NASDAQ:INVA) Lowered to Buy Rating by Wall Street Zen - MarketBeat
Brokerages Set Innoviva, Inc. (NASDAQ:INVA) PT at $37.60 - Defense World
Order flow analysis tools used on Innoviva Inc.Portfolio Value Summary & Stepwise Trade Execution Plans - newser.com
Innoviva (NASDAQ:INVA) Research Coverage Started at The Goldman Sachs Group - Defense World
Is Innoviva Inc. showing signs of accumulationQuarterly Profit Review & Community Driven Trade Alerts - newser.com
What Does Technical Analysis Say About Star Delta Transformers Limited StockInflation Impact on Stocks & Market Volatility Strategies - earlytimes.in
Innoviva (NASDAQ:INVA) Coverage Initiated at The Goldman Sachs Group - MarketBeat
What analysts say about Innoviva Inc stockSmall Cap Stock Opportunities & Achieve Explosive Results - earlytimes.in
Multi factor analysis applied to Innoviva Inc.2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Innoviva Inc Stock (INVA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):